Patent details
EP3131631 Title: SITAGLIPTIN TANNATE COMPLEX
Basic Information
- Publication number:
- EP3131631
- PCT Application Number:
- US2015025504
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP157800459
- PCT Publication Number:
- WO2015160678
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SITAGLIPTIN TANNATE COMPLEX
- French Title of Invention:
- COMPLEXE DE TANNATE DE SITAGLIPTINE
- German Title of Invention:
- SITAGLIPTIN-TANNAT-KOMPLEXE
- SPC Number:
Dates
- Filing date:
- 13/04/2015
- Grant date:
- 16/11/2022
- EP Publication Date:
- 22/02/2017
- PCT Publication Date:
- 22/10/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 16/11/2022
- EP B1 Publication Date:
- 16/11/2022
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 13/04/2023
- Expiration date:
- 13/04/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 09/11/2022
- Name:
- Merck Sharp & Dohme LLC
- Address:
- 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States (US)
Inventor
1
- Name:
- BURLAGE, Rubi
- Address:
- United States (US)
2
- Name:
- OMWANCHA, Wycliffe
- Address:
- United States (US)
Priority
- Priority Number:
- 201461980641 P
- Priority Date:
- 17/04/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61P 3/08; C07D 487/04; A61K 31/4985; A61K 31/496; A61K 31/7032; A61K 9/00; A61K 45/06;
Publication
European Patent Bulletin
- Issue number:
- 202246
- Publication date:
- 16/11/2022
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|